Skip to content

Released Apr 24, 2013, after the close

10-Q filed Apr 24, 2013, 24 days after period end · 0001477932-13-001980

Q1 2013 · 10-Q
Revenue—
Net Income-$1.35MN/M vs Q1 2012N/M vs Q4 2012
EPS Diluted-$0.30N/M vs Q1 2012no prior Q4 2012 on file
Operating Income-$1,352,147N/M
Operating Cash Flow-$119N/M
Free Cash Flowderived-$1,325—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2013Q1 2012
Net Income-$1.35M-$61.23K
EPS Diluted-$0.30-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR